Table 4.
Gene_ID | Group | Number of subjects | p value a | |
---|---|---|---|---|
Non-Meth. | Meth. | |||
OPG2_CpG_1 | Control | 27 | 23 | 0.001 |
Case | 10 | 39 | ||
OPG2_CpG_5 | Control | 30 | 17 | 0.039 |
Case | 20 | 27 | ||
OPG2_CpG_10.11 | Control | 42 | 6 | 0.007 |
Case | 32 | 18 | ||
RANK1_CpG_2 | Control | 17 | 32 | 0.008 |
Case | 6 | 44 | ||
RANK1_CpG_6 | Control | 18 | 30 | 0.004 |
Case | 6 | 43 | ||
RANK1_CpG_18 | Control | 16 | 33 | 0.028 |
Case | 7 | 43 | ||
RANK1_CpG_20 | Control | 34 | 15 | 0.001 |
Case | 18 | 32 | ||
RANK1_CpG_24.25.26.27 | Control | 16 | 32 | 0.013 |
Case | 6 | 43 | ||
RANK2_CpG_10.11 | Control | 19 | 27 | 0.012 |
Case | 9 | 41 | ||
RANK2_CpG_15 | Control | 33 | 14 | 0.003 |
Case | 20 | 30 | ||
RANK2_CpG_23.24.25.26.27 | Control | 33 | 14 | 0.005 |
Case | 21 | 29 | ||
RANK2_CpG_36 | Control | 40 | 7 | 0.048 |
Case | 34 | 16 | ||
RANK3_CpG_8 | Control | 25 | 21 | < 0.001 |
Case | 10 | 40 | ||
RANKL1_CpG_14.15 | Control | 16 | 28 | 0.044 |
Case | 9 | 41 | ||
RANKL1_CpG_19 | Control | 23 | 20 | 0.015 |
Case | 14 | 35 | ||
RANKL1_CpG_21 | Control | 34 | 10 | 0.018 |
Case | 27 | 23 | ||
RANKL1_CpG_24 | Control | 26 | 20 | 0.027 |
Case | 17 | 33 | ||
RANKL2_CpG_2 | Control | 18 | 30 | 0.003 |
Case | 6 | 44 | ||
RANKL2_CpG_9.10.11.12 | Control | 29 | 19 | < 0.001 |
Case | 9 | 41 |
Non-Meth Non-Methylation; Meth Methylation
p < 0.05 indicates statistical significance
a chi-square test